Clinical Trial Update: Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating botulinum toxin injections into the palatopharyngeal muscle for obstructive sleep apnea; the study is currently not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Hospital Felicio Rocho | Conditions: Sleep Apnea Syndrome, Obstructive, Sleep Apnea Syndrome (OSAS) | Phase 2 | Status: NOT_YET_RECRUITING